For in vivo rodent research: BPC-157 : 10 g/kg/day subcutaneous or intraperitoneal, 2-4 weeks TB-500 : 2-3 mg cumulative over 2-3 injections per week, 4-6 weeks Stack : same independent doses, separate or combined injections Clinical human protocols have not yet been standardized the few phase I/II trials used doses empirically derived from animal models
Safe Preparation for Injectable Medications: Ideal for medications requiring sterile water as a diluent
Furthermore, incorporating Sarcodon imbricatus or consuming a blend of Angelica gigas, Cnidium officinale, Paeonia lactiflora, moxibustion, cistanche, ginkgo extractsand, and ginseng has shown potential in restoring antioxidant balance and reducing fatigue in ME/CFS models in mice [120,121,122,123,124]
Pellentesque habitant morbi tristique senectus et netus et malesuada fames ac turpis egestas
Whats Behind Irritable Bowel Syndrome